Pruritus, commonly known as itching, is an unpleasant sensation that prompts the urge to scratch. Itching can occur anywhere on the body, but is often caused by dry skin, insect bites, skin infections, kidney or liver disease, malnutrition, medications, stress, and other medical conditions. The use of pruritus therapeutics such as antihistamines, counterirritants, local anesthetics, corticosteroids, immunosuppressants, and moisturizers provide effective relief from itching.
The global Pruritus Therapeutics Market is estimated to be valued at US$ 70.64 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising prevalence of skin disorders such as atopic dermatitis, psoriasis, urticaria, scabies, and others has increased the need for pruritus therapeutics to manage itching symptoms. This serves as a key driver for market growth. According to the International Forum for Dermatology Research, nearly 20% of the global population suffers from skin diseases and around 300,000 new cases of skin diseases are reported annually in the United States alone. Thus, increasing skin disorder cases have accelerated the demand for anti-itch medications to curb pruritus symptoms effectively.
Segment Analysis
The global pruritus therapeutics market size can be segmented based on type into acute pruritus, skin infections, chronic pruritus, kidney disorders, drug-induced pruritus, and others. The chronic pruritus segment dominates the market as chronic pruritus is characterized by long-term itching that lasts for over six weeks. Some of the common causes of chronic pruritus include aging, skin dryness, atopic dermatitis, and urticaria.
Key Takeaways
The global pruritus therapeutics market is expected to witness high growth over the forecast period. Growing geriatric population where incidence of chronic pruritic conditions is higher presents an opportunity.
Regional analysis: North America holds the largest share of the pruritus therapeutics market owing to the growing prevalence of atopic dermatitis and easy access to modern healthcare technologies in this region. Europe is the second largest market due to established healthcare infrastructure and high healthcare spending.
Key players: Key players operating in the pruritus therapeutics market include Levantina, Polycor, Indian Natural Stones, Topalidis, Dermitzakis, Antolini, Amso, Pakistan Onyx Marble & Granite, Etgran, Mumal Marbles, Tepia, Arizona Tile, Vetter Stone, Tekmarble & Granite, Temerty Stone, Dal Tile, M S International, Pokarna Limited, Cosentino.
Get more insights on this topic: https://www.newsstatix.com/pruritus-therapeutics-market-share-and-opportunity-analysis/
Explore more information, Please visit: https://filmik.in/cracking-the-code-of-epigenetics-the-harmony-of-gene-expression-outside-of-dna/
Comments
0 comment